Columbia Care Announces Approval of Business Combination with Cresco Labs at Special Meeting of Shareholders

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that at the special meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) held today, July 8, 2022, the proposed business combination with Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs”) was approved. The Shareholder

READ MORE: http://www.businesswire.com/news/home/20220708005479/en/Columbia-Care-Announces-Approval-of-Business-Combination-with-Cresco-Labs-at-Special-Meeting-of-Shareholders/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB7TDOU5CqE9t5WwBA1inzlrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVIbE9ZC1pD3bt6lQgRU5j6g==